EOLS
Evolus Inc
Price:  
10.18 
USD
Volume:  
745,245.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS Intrinsic Value

-338.30 %
Upside

What is the intrinsic value of EOLS?

As of 2025-06-13, the Intrinsic Value of Evolus Inc (EOLS) is (24.25) USD. This EOLS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 10.18 USD, the upside of Evolus Inc is -338.30%.

The range of the Intrinsic Value is (92.13) - (14.65) USD

Is EOLS undervalued or overvalued?

Based on its market price of 10.18 USD and our intrinsic valuation, Evolus Inc (EOLS) is overvalued by 338.30%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

10.18 USD
Stock Price
(24.25) USD
Intrinsic Value
Intrinsic Value Details

EOLS Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (92.13) - (14.65) (24.25) -338.3%
DCF (Growth 10y) (17.12) - (102.50) (27.81) -373.2%
DCF (EBITDA 5y) (6.83) - (8.67) (1,234.50) -123450.0%
DCF (EBITDA 10y) (9.81) - (12.90) (1,234.50) -123450.0%
Fair Value -4.36 - -4.36 -4.36 -142.81%
P/E (17.03) - (16.14) (16.65) -263.5%
EV/EBITDA (5.51) - (5.12) (5.65) -155.5%
EPV (6.65) - (10.38) (8.52) -183.7%
DDM - Stable (9.29) - (102.89) (56.09) -651.0%
DDM - Multi (12.24) - (110.30) (22.43) -320.3%

EOLS Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 656.41
Beta 0.92
Outstanding shares (mil) 64.48
Enterprise Value (mil) 710.32
Market risk premium 4.60%
Cost of Equity 7.66%
Cost of Debt 8.95%
WACC 7.87%